Tag Archives: Fluxion Biosciences

May 2016—Fluxion Biosciences has launched two kits for enhanced circulating tumor cell isolation and recovery that are designed to work exclusively with the IsoFlux Liquid Biopsy system.

Fluxion Biosciences and Swift Biosciences announced a jointly developed workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The workflow uses Fluxion’s IsoFlux System for circulating tumor cell enrichment and Swift’s Accel-Amplicon technology for high-sensitivity variant detection using low starting inputs.